Guidance on handheld inhalers in asthma and COPD guidelines

P N Richard Dekhuijzen, Leif Bjermer, Federico Lavorini, Vincent Ninane, Mathieu Molimard, John Andrew Francis Haughney

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

BACKGROUND: Inhaled therapy is the cornerstone of pharmacotherapy in patients with asthma and chronic obstructive pulmonary disease (COPD). Appropriate inhalation device selection is as important as drug choice but device-specific guidance appears to be lacking.

METHODS: To quantify the level of inhalation-device recommendations in clinical guidelines, a review was conducted by hand-searching national and international asthma and COPD guidelines (Global Initiative for Asthma [GINA] and Global initiative for chronic Obstructive Lung Disease [GOLD] guidelines) and an international guideline on device selection (the American College of Chest Physicians/American College of Asthma, Allergy, and Immunology [ACCP/ACAAI]). For each guideline, the number of pages, tables/figures and references relating to inhalation devices was identified.

RESULTS: GINA and GOLD guidelines contain very little inhalation device-specific guidance beyond recommendations for demonstrating and testing correct inhalation technique: <2% of pages or references and <3% of tables/figures are dedicated to devices. Device-related content in the ACCP/ACAAI device selection guideline was considerably higher with 54% of pages, 88% of tables/figures and 82% of references, respectively. Results in national guidelines reflect those on international guidelines.

CONCLUSIONS: These results indicate that there is a considerable lack of clear and specific guidance regarding inhalation devices in current asthma/COPD guidelines. More robust studies on the impact of inhalation devices are needed to increase the number of evidence statements and recommendations regarding inhalation devices.

Original languageEnglish
Pages (from-to)694-700
Number of pages7
JournalRespiratory Medicine
Volume108
Issue number5
Early online date1 Mar 2014
DOIs
Publication statusPublished - May 2014

Fingerprint

Nebulizers and Vaporizers
Chronic Obstructive Pulmonary Disease
Asthma
Guidelines
Equipment and Supplies
Allergy and Immunology
Inhalation
Thorax
Physicians
Drug Therapy

Keywords

  • Administration, Inhalation
  • Asthma
  • Bronchodilator Agents
  • Equipment Design
  • Humans
  • Nebulizers and Vaporizers
  • Practice Guidelines as Topic
  • Pulmonary Disease, Chronic Obstructive
  • Respiratory System Agents

Cite this

Dekhuijzen, P. N. R., Bjermer, L., Lavorini, F., Ninane, V., Molimard, M., & Haughney, J. A. F. (2014). Guidance on handheld inhalers in asthma and COPD guidelines. Respiratory Medicine, 108(5), 694-700. https://doi.org/10.1016/j.rmed.2014.02.013

Guidance on handheld inhalers in asthma and COPD guidelines. / Dekhuijzen, P N Richard; Bjermer, Leif; Lavorini, Federico; Ninane, Vincent; Molimard, Mathieu; Haughney, John Andrew Francis.

In: Respiratory Medicine, Vol. 108, No. 5, 05.2014, p. 694-700.

Research output: Contribution to journalArticle

Dekhuijzen, PNR, Bjermer, L, Lavorini, F, Ninane, V, Molimard, M & Haughney, JAF 2014, 'Guidance on handheld inhalers in asthma and COPD guidelines', Respiratory Medicine, vol. 108, no. 5, pp. 694-700. https://doi.org/10.1016/j.rmed.2014.02.013
Dekhuijzen PNR, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney JAF. Guidance on handheld inhalers in asthma and COPD guidelines. Respiratory Medicine. 2014 May;108(5):694-700. https://doi.org/10.1016/j.rmed.2014.02.013
Dekhuijzen, P N Richard ; Bjermer, Leif ; Lavorini, Federico ; Ninane, Vincent ; Molimard, Mathieu ; Haughney, John Andrew Francis. / Guidance on handheld inhalers in asthma and COPD guidelines. In: Respiratory Medicine. 2014 ; Vol. 108, No. 5. pp. 694-700.
@article{e6a905ea56ed45a8abe33a7050405dac,
title = "Guidance on handheld inhalers in asthma and COPD guidelines",
abstract = "BACKGROUND: Inhaled therapy is the cornerstone of pharmacotherapy in patients with asthma and chronic obstructive pulmonary disease (COPD). Appropriate inhalation device selection is as important as drug choice but device-specific guidance appears to be lacking.METHODS: To quantify the level of inhalation-device recommendations in clinical guidelines, a review was conducted by hand-searching national and international asthma and COPD guidelines (Global Initiative for Asthma [GINA] and Global initiative for chronic Obstructive Lung Disease [GOLD] guidelines) and an international guideline on device selection (the American College of Chest Physicians/American College of Asthma, Allergy, and Immunology [ACCP/ACAAI]). For each guideline, the number of pages, tables/figures and references relating to inhalation devices was identified.RESULTS: GINA and GOLD guidelines contain very little inhalation device-specific guidance beyond recommendations for demonstrating and testing correct inhalation technique: <2{\%} of pages or references and <3{\%} of tables/figures are dedicated to devices. Device-related content in the ACCP/ACAAI device selection guideline was considerably higher with 54{\%} of pages, 88{\%} of tables/figures and 82{\%} of references, respectively. Results in national guidelines reflect those on international guidelines.CONCLUSIONS: These results indicate that there is a considerable lack of clear and specific guidance regarding inhalation devices in current asthma/COPD guidelines. More robust studies on the impact of inhalation devices are needed to increase the number of evidence statements and recommendations regarding inhalation devices.",
keywords = "Administration, Inhalation, Asthma, Bronchodilator Agents, Equipment Design, Humans, Nebulizers and Vaporizers, Practice Guidelines as Topic, Pulmonary Disease, Chronic Obstructive, Respiratory System Agents",
author = "Dekhuijzen, {P N Richard} and Leif Bjermer and Federico Lavorini and Vincent Ninane and Mathieu Molimard and Haughney, {John Andrew Francis}",
note = "Copyright {\circledC} 2014 Elsevier Ltd. All rights reserved.",
year = "2014",
month = "5",
doi = "10.1016/j.rmed.2014.02.013",
language = "English",
volume = "108",
pages = "694--700",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Guidance on handheld inhalers in asthma and COPD guidelines

AU - Dekhuijzen, P N Richard

AU - Bjermer, Leif

AU - Lavorini, Federico

AU - Ninane, Vincent

AU - Molimard, Mathieu

AU - Haughney, John Andrew Francis

N1 - Copyright © 2014 Elsevier Ltd. All rights reserved.

PY - 2014/5

Y1 - 2014/5

N2 - BACKGROUND: Inhaled therapy is the cornerstone of pharmacotherapy in patients with asthma and chronic obstructive pulmonary disease (COPD). Appropriate inhalation device selection is as important as drug choice but device-specific guidance appears to be lacking.METHODS: To quantify the level of inhalation-device recommendations in clinical guidelines, a review was conducted by hand-searching national and international asthma and COPD guidelines (Global Initiative for Asthma [GINA] and Global initiative for chronic Obstructive Lung Disease [GOLD] guidelines) and an international guideline on device selection (the American College of Chest Physicians/American College of Asthma, Allergy, and Immunology [ACCP/ACAAI]). For each guideline, the number of pages, tables/figures and references relating to inhalation devices was identified.RESULTS: GINA and GOLD guidelines contain very little inhalation device-specific guidance beyond recommendations for demonstrating and testing correct inhalation technique: <2% of pages or references and <3% of tables/figures are dedicated to devices. Device-related content in the ACCP/ACAAI device selection guideline was considerably higher with 54% of pages, 88% of tables/figures and 82% of references, respectively. Results in national guidelines reflect those on international guidelines.CONCLUSIONS: These results indicate that there is a considerable lack of clear and specific guidance regarding inhalation devices in current asthma/COPD guidelines. More robust studies on the impact of inhalation devices are needed to increase the number of evidence statements and recommendations regarding inhalation devices.

AB - BACKGROUND: Inhaled therapy is the cornerstone of pharmacotherapy in patients with asthma and chronic obstructive pulmonary disease (COPD). Appropriate inhalation device selection is as important as drug choice but device-specific guidance appears to be lacking.METHODS: To quantify the level of inhalation-device recommendations in clinical guidelines, a review was conducted by hand-searching national and international asthma and COPD guidelines (Global Initiative for Asthma [GINA] and Global initiative for chronic Obstructive Lung Disease [GOLD] guidelines) and an international guideline on device selection (the American College of Chest Physicians/American College of Asthma, Allergy, and Immunology [ACCP/ACAAI]). For each guideline, the number of pages, tables/figures and references relating to inhalation devices was identified.RESULTS: GINA and GOLD guidelines contain very little inhalation device-specific guidance beyond recommendations for demonstrating and testing correct inhalation technique: <2% of pages or references and <3% of tables/figures are dedicated to devices. Device-related content in the ACCP/ACAAI device selection guideline was considerably higher with 54% of pages, 88% of tables/figures and 82% of references, respectively. Results in national guidelines reflect those on international guidelines.CONCLUSIONS: These results indicate that there is a considerable lack of clear and specific guidance regarding inhalation devices in current asthma/COPD guidelines. More robust studies on the impact of inhalation devices are needed to increase the number of evidence statements and recommendations regarding inhalation devices.

KW - Administration, Inhalation

KW - Asthma

KW - Bronchodilator Agents

KW - Equipment Design

KW - Humans

KW - Nebulizers and Vaporizers

KW - Practice Guidelines as Topic

KW - Pulmonary Disease, Chronic Obstructive

KW - Respiratory System Agents

U2 - 10.1016/j.rmed.2014.02.013

DO - 10.1016/j.rmed.2014.02.013

M3 - Article

VL - 108

SP - 694

EP - 700

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

IS - 5

ER -